We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
-9.76%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$297M
AUM Growth
-$40.3M
Cap. Flow
-$2.87M
Cap. Flow %
-0.97%
Top 10 Hldgs %
35.05%
Holding
362
New
12
Increased
34
Reduced
87
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 22.58%
2 Healthcare 15.32%
3 Consumer Staples 14.98%
4 Miscellaneous 12.74%
5 Financials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
26
Automatic Data Processing
ADP
$114B
$3.38M 1.14%
25,814
-310
-1% -$43.8K
PM icon
27
Philip Morris
PM
$299B
$3.15M 1.06%
47,124
-4,753
-9% -$397K
BIIB icon
28
Biogen
BIIB
$32.3B
$3.13M 1.05%
10,390
-25
-0.2% -$7.98K
MKC icon
29
McCormick & Company Non-Voting
MKC
$14.9B
$3.08M 1.04%
44,270
-600
-1% -$43K
SYK icon
30
Stryker
SYK
$127B
$2.75M 0.93%
17,560
-430
-2% -$71.9K
MSFT icon
31
Microsoft
MSFT
$3.81T
$2.73M 0.92%
26,860
-950
-3% -$102K
WLY icon
32
John Wiley & Sons Class A
WLY
$2.73B
$2.43M 0.82%
51,800
-850
-2% -$45.8K
TFX icon
33
Teleflex
TFX
$5.92B
$2.42M 0.82%
9,375
-384
-4% -$97.2K
TD icon
34
Toronto Dominion Bank
TD
$199B
$2.28M 0.77%
45,786
-550
-1% -$30.1K
NVDA icon
35
NVIDIA
NVDA
$5.25T
$2.21M 0.74%
660,600
-20,400
-3% -$97.6K
USB.PRM
36
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$2.16M 0.73%
81,575
-1,300
-2% -$34.7K
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.08M 0.7%
10,170
-325
-3% -$67.9K
MRK icon
38
Merck
MRK
$366B
$2.08M 0.7%
28,479
-944
-3% -$66.6K
DD icon
39
DuPont de Nemours
DD
$18.5B
$1.99M 0.67%
14,713
-450
-3% -$64.6K
RTX icon
40
RTX Corp
RTX
$285B
$1.97M 0.67%
29,446
+153
+0.5% +$12K
PFE icon
41
Pfizer
PFE
$159B
$1.96M 0.66%
47,314
-105
-0.2% -$4.36K
TRP icon
42
TC Energy
TRP
$64.4B
$1.86M 0.63%
52,229
-600
-1% -$23.7K
VRTX icon
43
Vertex Pharmaceuticals
VRTX
$137B
$1.86M 0.63%
11,200
HCI icon
44
HCI Group
HCI
$2.32B
$1.85M 0.62%
36,400
-300
-0.8% -$14.7K
HP icon
45
Helmerich & Payne
HP
$4.25B
$1.6M 0.54%
33,335
-8,010
-19% -$492K
RMD icon
46
ResMed
RMD
$34.7B
$1.53M 0.52%
13,415
-200
-1% -$21.4K
EL icon
47
Estee Lauder
EL
$37.4B
$1.48M 0.5%
11,370
+3,915
+53% +$532K
LQD icon
48
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.44M 0.49%
12,760
-800
-6% -$89.9K
GILD icon
49
Gilead Sciences
GILD
$181B
$1.32M 0.45%
21,190
-7,170
-25% -$501K
HRL icon
50
Hormel Foods
HRL
$11.9B
$1.32M 0.45%
31,055
+775
+3% +$33.4K

Similar funds

American Research & Management Company's Q4 2018 Portfolio in Review

As of Q4 2018, American Research & Management Company held 362 positions worth $297M, down 12% from $337M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company's Q4 2018 filing shows 12 new, 34 increased, 87 reduced and 28 closed positions. Its largest new stake was Energy Transfer Partners: 74,971 shares worth $990K. The largest sale was IBM, an estimated $1.35M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

  • American Research & Management Company's largest Q4 2018 buy was Energy Transfer Partners: 74,971 shares worth $990K.
  • American Research & Management Company added most to Alphabet (Google) Class C in Q4 2018, an estimated $1.54M increase.
  • American Research & Management Company's biggest Q4 2018 reduction was IBM, cutting an estimated $1.35M.
  • American Research & Management Company fully exited Energy Transfer Partners L.p. in Q4 2018, selling an estimated $928K.
  • American Research & Management Company's ten largest holdings make up 35% of its $297M portfolio in Q4 2018.
  • American Research & Management Company opened 12 new positions and closed 28 in Q4 2018.
  • American Research & Management Company's portfolio value fell 12% quarter-over-quarter to $297M.

Based on American Research & Management Company's 13F filing for Q4 2018, filed 12 Feb 2019.